PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Sep-2024 New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution AccessWire
18-Sep-2024 New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution Newswire
18-Sep-2024 Faro Health Joins Veeva Product Partner Program Newswire
18-Sep-2024 MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025 AccessWire
18-Sep-2024 Faro Health Joins Veeva Product Partner Program AccessWire
18-Sep-2024 MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025 Newswire
18-Sep-2024 Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis Immunic AG
18-Sep-2024 Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus AccessWire
18-Sep-2024 GP industrial action will undo progress made in accessing surgeries: expert London Medical Laboratory
18-Sep-2024 RSSL announces opening of new laboratory to provide advanced 3D imaging and metrology services RSSL
18-Sep-2024 Bioz Stars Revolutionizes Product Selection in Scientific Research With Objective Ratings AccessWire
18-Sep-2024 Cordlife Unveils Enhanced Processing and Storage Facility in Singapore Cordlife Group Limited
18-Sep-2024 Alfa Chemistry Enhances Household Care with a Range of Surfactants: Emulsifying, Dispersing, Antistatic, and Foaming Agents Alfa Chemistry
18-Sep-2024 Alfa Chemistry Provides Alkaloids-Related Natural Products: Saccharides, Flavonoids, Terpenoids, etc Alfa Chemistry
18-Sep-2024 Innovation Brings New Possibilities: Alfa Chemistry Newly Releases Copper Alloys, Nickel Alloys, and Titanium Alloys Alfa Chemistry
18-Sep-2024 Explore Global Trends in Hepatocellular Carcinoma Prophecy Market Insights
18-Sep-2024 Exploring Growth of Artificial Intelligence (AI) in Biotechnology Prophecy Market Insights
18-Sep-2024 Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 AccessWire
18-Sep-2024 Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 Relief Therapeutics Holding SA
17-Sep-2024 Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules AccessWire